Related Experiment Video
Updated: Jul 26, 2026

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
Graduated Compression Stockings as an Adjunct to Low Dose Low Molecular Weight Heparin in Venous Thromboembolism
J Shalhoub1, J Norrie2, C Baker3
1Academic Section of Vascular Surgery, Department of Surgery & Cancer, Imperial College London, UK.
Insights
This study investigates if low dose low molecular weight heparin (LMWH) alone is as effective as LMWH with graduated compression stockings (GCS) for preventing venous thromboembolism (VTE) in surgical patients.
Area of Science:
- Medical research
- Clinical trials
- Thromboprophylaxis
Background:
- Current venous thromboembolism (VTE) prevention guidelines lack optimal evidence.
- Graduated compression stockings (GCS) represent a significant cost in VTE prevention for surgical patients.
Purpose of the Study:
- To determine if low dose low molecular weight heparin (LMWH) monotherapy is non-inferior to combination therapy (LMWH + GCS) for VTE prevention.
- To evaluate the efficacy and safety of LMWH alone versus LMWH with GCS in surgical patients at moderate to high risk of VTE.
Main Methods:
- The Graduated compression as an Adjunct to Pharmacoprophylaxis in Surgery (GAPS) Trial is a randomized controlled trial.
- Adult elective surgical patients at moderate/high VTE risk will be randomized to LMWH alone or LMWH + GCS.
- The study requires 2236 patients across seven UK centers to demonstrate non-inferiority for VTE within 90 days.
Main Results:
- Primary endpoint is the incidence of all VTE within 90 days, with a non-inferiority margin of 3.5%.
- Secondary outcomes include quality of life, compliance, mortality, and bleeding complications.
Conclusions:
- The GAPS trial aims to provide crucial evidence on optimizing VTE prevention strategies.
- Findings will inform recommendations regarding the necessity of GCS in conjunction with LMWH for surgical patients.
Background:
The evidence base upon which current global venous thromboembolism (VTE) prevention recommendations have been made is not optimal. The cost of purchasing and applying graduated compression stockings (GCS) in surgical patients is considerable and has been estimated at £63.1 million per year in England alone.
Objective:
The aim was to determine whether low dose low molecular weight heparin (LMWH) alone is non-inferior to a combination of GCS and low dose LMWH for the prevention of VTE.
Methods:
The randomised controlled Graduated compression as an Adjunct to Pharmacoprophylaxis in Surgery (GAPS) Trial (ISRCTN 13911492) will randomise adult elective surgical patients identified as being at moderate and high risk of VTE to receive either the current "standard" combined thromboprophylactic LMWH with GCS mechanical thromboprophylaxis, or thromboprophylactic LMWH pharmacoprophylaxis alone. To show non-inferiority (3.5% non-inferiority margin) for the primary endpoint of all VTE within 90 days, 2236 patients are required. Recruitment will be from seven UK centres. Secondary outcomes include quality of life, compliance with stockings and LMWH, overall mortality, and GCS or LMWH related complications (including bleeding). Recruitment commenced in April 2016 with the seven UK centres coming "on-line" in a staggered fashion. Recruitment will be over a total of 18 months. The GAPS trial is funded by the National Institute for Health Research Health Technology Assessment in the UK (14/140/61).
More Related Videos
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Peripheral Artery Disease V: Postoperative Nursing Management
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management

